caBIG^® and China

Background

Founded in 1976, the Beijing Cancer Hospital (Peking University School of Oncology and Beijing Institute for Cancer Research) is a cancer prevention and treatment research center that provides medical treatment, education, research prevention, and rehabilitation services. The Beijing Cancer Hospital is one of the most renowned cancer treatment hospitals in China—treating more than 150,000 patients per year—and represents a substantial data source for cancer researchers worldwide.

About the Partnership

The Duke University Comprehensive Cancer Center (DCCC) and the Beijing Cancer Hospital launched a pilot collaboration in 2009 using caBIG^® tools and technology. This collaboration marks the first clinical trial in China to conduct all patient registrations electronically and will utilize caBIG^® applications for clinical trials management. The DCCC is also helping to facilitate adoption of caBIG^® standards in the broader Chinese health system.

Additional Resources

• Overview of China's Scientific Data Sharing Project on Basic Medicine
  Heng Wang, Ph.D., Director of the Institute of Basic Medical Sciences, CAMS
• Introduction and Principles of caBIG^®
  John Speakman, Associate Director of Clinical Trials Products and Programs, NCI CBIIT
• University of California San Francisco (UCSF) and Peking Union Medical College-CAMS Cancer Centers Program Partnership and Activities
  Sorena Nadaf, Director, Translational Bioinformatics and Chief Information Officer, Helen Diller Family Comprehensive Cancer Center, UCSF
• Overview of the Use of caBIG^® Tools for Joint Clinical Trials Research between Duke and Peking University
  Jun Ren, M.D., Ph.D., Executive Director, Clinical Trials Center, Beijing Cancer Hospital, Peking University
• Potential Collaboration on Clinical Epidemiological Studies and Prevention Trials in China
  Youlin Qiao, M.D., Ph.D., Director, Department of Cancer Epidemiology, Cancer Institute/Hospital of CAMS